Special care dentistry: Midazolam conscious sedation for patients with neurological diseases

Authors:

P. L. Capp
Dentistry Division, Hospital das Clinicas, Medical School, University of Sao Paulo, Brazil
M. E. de Faria
Dentistry Division, Hospital das Clinicas, Medical School, University of Sao Paulo, Brazil
S. R. Siqueira
Assistant Professor, School of Arts, Science and Humanity, Hospital das Clinicas, Medical School, University of Sao Paulo, Brazil
M. T. Cillo
General anesthesia and sedation, Dentistry Division, Hospital das Clinicas, Medical School, University of Sao Paulo, Brazil
E. G. Prado
Director of the Dentistry Division, Psychiatry Institute, Hospital das Clinicas, Medical School, University of Sao Paulo, Brazil
J. T. de Siqueira
Head of Orofacial Pain Team, Dentistry Division, Hospital das Clinicas, Medical School, University of Sao Paulo, Brazil

ABSTRACT

Aim

Midazolam is used very often to control the anxiety of patients for dental treatment, especially in patients with
special needs. The objective of this study was to evaluate the efficiency of Midazolam in patients with neurological diseases
referred for dental treatment. Study design: Descriptive study.

Methods

Forty consecutive patients with
neurological disorders (encephalopathy, autism, and epilepsy) were referred to dental treatment, and 45 sedations were
performed; all were sedated with Midazolam (intramuscular 0.2-0.3 mg/kg or intravenous 0.1mg/kg) and all were anesthetised
with lidocaine 2 (0.5-2 mL). During the dental procedure, their behavior was analysed and classified into 3
categories: A (indifferent), B (reacted but allowed treatment), and C (did not allow treatment). Data were tabbed and
statistically analysed.

Results

The final patients' classification was: A 22 (49), B 18 (40) and C 5
(11); the patients with encephalopathy had the best results of sedation according to the proposed classification
(p<0.05).

Conclusion

Midazolam demonstrated to be effective in 89 of this sample for dental procedures in
patients with neurological and behavioral disturbances, but it was less effective for patients with autism (p<0.05).

PLUMX METRICS

Publication date:

Dec /2010

Keywords:

conscious sedation, dental treatment, midazolam, special care, special need

Issue:

Vol.11 – n.4/2010

Page:

162 – 164

Publisher:

Ariesdue

Cite:

Harvard: P. L. Capp, M. E. de Faria, S. R. Siqueira, M. T. Cillo, E. G. Prado, J. T. de Siqueira (2010) "Special care dentistry: Midazolam conscious sedation for patients with neurological diseases", European Journal of Paediatric Dentistry, 11(4), pp162-164. doi:

Vancouver: P. L. Capp, M. E. de Faria, S. R. Siqueira, M. T. Cillo, E. G. Prado, J. T. de Siqueira. Special care dentistry: Midazolam conscious sedation for patients with neurological diseases. European Journal of Paediatric Dentistry [Internet]. 2010Dec.1 [cited 2023Mar.21];11(4):162-164. Available from: https://www.ejpd.eu/abstract-pubmed/special-care-dentistry-midazolam-conscious-sedation-for-patients-with-neurological-diseases/

MLA: P. L. Capp, M. E. de Faria, S. R. Siqueira, M. T. Cillo, E. G. Prado, J. T. de Siqueira Special care dentistry: Midazolam conscious sedation for patients with neurological diseases. European Journal of Paediatric Dentistry. 2010;11(4):162-164

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.